Wells Fargo & Company MN boosted its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 22.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,918 shares of the company's stock after purchasing an additional 5,809 shares during the quarter. Wells Fargo & Company MN owned about 0.18% of Addus HomeCare worth $4,001,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently added to or reduced their stakes in the company. Barclays PLC increased its position in Addus HomeCare by 204.8% during the 3rd quarter. Barclays PLC now owns 43,470 shares of the company's stock valued at $5,783,000 after buying an additional 29,207 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Addus HomeCare by 7.1% during the third quarter. Geode Capital Management LLC now owns 423,934 shares of the company's stock valued at $56,406,000 after acquiring an additional 28,284 shares in the last quarter. Franklin Resources Inc. raised its position in shares of Addus HomeCare by 2.7% in the 3rd quarter. Franklin Resources Inc. now owns 26,216 shares of the company's stock valued at $3,456,000 after purchasing an additional 701 shares during the last quarter. Principal Financial Group Inc. raised its position in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock valued at $67,293,000 after purchasing an additional 75,409 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in Addus HomeCare by 10.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company's stock worth $24,371,000 after purchasing an additional 16,997 shares in the last quarter. Institutional investors own 95.35% of the company's stock.
Analyst Ratings Changes
A number of research firms have issued reports on ADUS. JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Tuesday. Stephens reaffirmed an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. Macquarie reissued an "outperform" rating and issued a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, Oppenheimer increased their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of "Buy" and an average price target of $139.00.
Check Out Our Latest Stock Report on ADUS
Addus HomeCare Stock Up 1.0 %
Shares of NASDAQ:ADUS traded up $1.04 during trading on Friday, hitting $100.58. 97,408 shares of the stock traded hands, compared to its average volume of 162,977. The company has a fifty day moving average price of $97.93 and a two-hundred day moving average price of $116.15. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72. The company has a market cap of $1.83 billion, a price-to-earnings ratio of 23.02, a P/E/G ratio of 1.41 and a beta of 0.93.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $297.14 million during the quarter, compared to analysts' expectations of $291.04 million. On average, equities research analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
